Overview

The global external defibrillator market was valued at USD 4.25 billion in 2025 and is projected to reach USD 8.2 billion by 2032, expanding at a CAGR of 9.8% from 2026 to 2032. This market is driven by the rapidly rising global incidence of sudden cardiac arrest (SCA), increasing public access defibrillation (PAD) program deployment across developed and emerging economies, and tightening regulatory frameworks mandating defibrillator availability in public spaces, schools, sports facilities, and corporate buildings. Heightened public awareness about cardiac emergency response catalyzed by high-profile athlete cardiac arrest events and global CPR/AED awareness campaigns is propelling demand across hospital, pre-hospital, public access, and home care settings worldwide. According to the American Heart Association, sudden cardiac arrest claims approximately 356,000 lives annually in the United States alone, with survival rates highly dependent on the time-to-defibrillation interval each minute of delay reduces survival probability by 7-10%, creating a compelling clinical and public health rationale for widespread external defibrillator availability.

 

The expanding global hospital infrastructure and emergency medical services (EMS) network is a key structural driver for the market, supplemented by direct government healthcare investment programs. The UK NHS New Hospital Programme committed GBP 20 billion to building 40 new hospitals by 2030, each requiring comprehensive defibrillator capability. The European Resuscitation Council (ERC) Guidelines 2021 provide harmonized clinical standards driving AED deployment across European Union member states, supported by EU public health funding under the EU4Health programme of EUR 5.3 billion (2021-2027). Advancements in defibrillator technology including AI-enhanced rhythm analysis, smartphone-connected AEDs with cloud-based deployment tracking, real-time CPR feedback, pediatric mode integration, and wearable cardioverter defibrillators for at-risk patients are enabling manufacturers to develop highly differentiated products. 

Market Size & Share

Market Dynamics

Adoption of Smart, Connected, and AI-Enabled Defibrillator Technology is the Key Trend

The external defibrillator market is experiencing a prominent trend of accelerating shift from standalone manual and basic AED devices toward connected, AI-enhanced, and smartphone-integrated defibrillator systems with real-time telemetry, cloud-based deployment management, and integrated CPR feedback capabilities. Modern AEDs increasingly incorporate Wi-Fi and cellular connectivity that enables real-time device readiness monitoring, automatic battery and pad expiration alerts, post-event data upload to clinical care providers, and integration with EMS dispatch systems for accelerated response. The U.S. National Institutes of Health (NIH) Heart, Lung, and Blood Institute (NHLBI) has invested over USD 100 million annually in cardiovascular research including resuscitation science and defibrillation technology development, supporting the scientific foundation for next-generation device innovation. The U.S. FDA's premarket approval pathway has cleared multiple AI-enhanced AEDs incorporating advanced rhythm analysis algorithms that improve shock decision accuracy and reduce false-positive shock advisories.

 

Rising Incidence of Sudden Cardiac Arrest and Public Access Defibrillation Mandates is the Key Driver

The mounting global burden of sudden cardiac arrest combined with expanding government and regulatory mandates for AED deployment in public spaces is a fundamental growth driver for the global external defibrillator market. The World Health Organization (WHO) estimates that cardiovascular diseases cause approximately 17.9 million deaths annually worldwide, with sudden cardiac arrest representing a significant component. Australia's Heart of the Nation initiative, supported by federal and state government grants exceeding AUD 4 million, has registered over 25,000 AEDs in its national database. France's mandatory AED deployment law (Decree 2018-1186) requires AED installation in establishments receiving the public above defined capacity thresholds. The European Resuscitation Council Guidelines provide clinical standards driving institutional AED procurement, while the EU's Cardiovascular Plan of Action and national heart disease strategies across member states are accelerating PAD program expansion.

 

Wearable Cardioverter Defibrillators and Home Care Adoption Presents Key Opportunity

The broadening application scope of external defibrillators beyond traditional hospital and public access settings into wearable cardioverter defibrillators (WCDs) for at-risk ambulatory patients and home care AED deployment for high-risk individuals represents a significant untapped opportunity for market players. Mindray's BeneHeart C1A AED was selected as the premier defibrillator by London Hearts (in partnership with Smarter Society) following a competitive tender by the UK Department of Health & Social Care for its £1 million Community Automated External Defibrillators Fund, supporting distribution of 2,000 AEDs across England, strengthening Mindray's footprint in the European public access defibrillator market. Wearable cardioverter defibrillators worn continuously by patients at temporary risk of sudden cardiac arrest following myocardial infarction, undergoing evaluation for implantable cardioverter defibrillator (ICD) candidacy, or with reduced ejection fraction conditions provide critical bridge protection during high-risk periods. The U.S. Centers for Medicare & Medicaid Services (CMS) provides reimbursement coverage for WCDs under defined clinical criteria, supporting commercial viability of this segment. ZOLL Medical's LifeVest is the established WCD platform with over 600,000 patients having received the therapy globally as of 2024, demonstrating the segment's scale and growth trajectory. The U.S. FDA's expanded clearances and CE Mark approvals for next-generation WCDs continue to extend the addressable patient population. 

Global External Defibrillator Market Size, 2021–2032 (USD Billion)

Segmentation Analysis

Analysis by Product Type

The automated external defibrillators (AEDs) segment held the largest category 40.0% in 2025, owing to its established role as the foundational device for both professional EMS deployment and lay-rescuer public access defibrillation programs globally. Within AEDs, semi-automated AEDs account for the dominant sub-segment, driven by clinical preference for explicit shock confirmation by the rescuer and broad regulatory acceptance across all major markets.

 

The wearable cardioverter defibrillators (WCD) segment will grow at the fastest CAGR of approximately 9.9% during the forecast period, driven by expanding clinical evidence supporting WCD use in temporary high-risk patient populations, growing CMS reimbursement coverage in the U.S., and expanding regulatory approvals globally. ZOLL Medical's LifeVest has provided protection to over 600,000 patients globally, demonstrating the proven clinical and commercial scale of this segment.

 

Product Type categories include:

•      Manual External Defibrillators

•      Automated External Defibrillators / AEDs (Largest Category)

•      Semi-Automated AED (Largest Sub-segment)

•      Fully Automated AED

•      Wearable Cardioverter Defibrillators / WCD (Fastest-Growing Category)

 

Analysis by Technology

The biphasic defibrillators segment held the larger category 85.0% in 2025 and it will also continue to grow at the faster CAGR of approximately 10.2% during the forecast period, due to its decisive clinical and regulatory dominance over monophasic technology following extensive evidence demonstrating biphasic waveform's superior efficacy at lower energy levels with reduced myocardial damage. Modern biphasic platforms incorporate advanced features including impedance-compensated truncated exponential waveforms, escalating energy protocols, and integrated CPR feedback capabilities, commanding premium pricing relative to legacy alternatives.

 

Technology categories include:

•      Biphasic Defibrillators (Larger Category and Faster-Growing Category)

•      Monophasic Defibrillators

 

Analysis by Patient Type

The adult segment held the larger category 80.0% in 2025, reflecting the predominantly adult demographic affected by sudden cardiac arrest and the design of standard defibrillator pads, energy protocols, and rescue algorithms for adult patients. Many public access AEDs are designed for adult use as the default configuration, with optional pediatric pad accessories or pediatric mode toggles for pediatric victims.

 

The pediatric segment will grow at the faster CAGR of approximately 10.1% during the forecast period, driven by growing institutional procurement of pediatric-capable AEDs in schools, daycare facilities, and pediatric healthcare settings. Government school AED mandates including those across all U.S. states and the UK Department for Education's GBP 19 million school deployment program are increasingly specifying devices with integrated or compatible pediatric attenuation capability.

 

Patient Type categories include:

•      Adult (Larger Category)

•      Pediatric (Faster-Growing Category)

 

Analysis by Distribution Channel

The direct sales / institutional procurement segment held the largest category 45.0% in 2025, reflecting the dominance of direct manufacturer-to-customer sales relationships in hospital, EMS, and large institutional procurement contexts. Government public procurement frameworks including the U.S. General Services Administration medical equipment schedules, the UK NHS Supply Chain framework, India's Government e-Marketplace (GeM) portal, and the EU's centralized public procurement platforms predominantly specify direct manufacturer engagement for defibrillator acquisition, supporting segment leadership.

 

The online / e-commerce segment will grow at the fastest CAGR of approximately 10.4% during the forecast period, propelled by growing AED procurement by small businesses, residential users, and community organizations seeking convenient access to defibrillator products and accessories. Online medical supply platforms including AED Superstore, AED Authority, and major e-commerce platforms have built specialized AED sales channels with technical support, training resources, and ongoing maintenance management.

 

Distribution Channel categories include:

•      Direct Sales / Institutional Procurement (Largest Category)

•      Distributors / Authorized Dealers

•      Online / E-commerce (Fastest-Growing Category)

•      Group Purchasing Organizations / GPOs

 

Analysis by Portability

The portable defibrillators segment held the largest category 65.0% in 2025, encompassing all AED platforms designed for rapid carriage and deployment to the point of cardiac emergency, as well as portable manual defibrillator-monitor combination devices used by EMS and hospital code teams. Portable platforms represent the dominant device configuration across virtually all end user settings given the time-critical nature of defibrillation requiring devices to be brought to the patient rather than vice versa.

 

The wearable defibrillators segment will grow at the fastest CAGR of approximately 10.6% during the forecast period, encompassing wearable cardioverter defibrillators (WCDs) prescribed for at-risk ambulatory patients. The U.S. CMS reimbursement coverage for WCDs under Medicare and Medicaid, combined with expanding commercial payer coverage, is supporting commercial growth of this segment.

Portability categories include:

•      Portable Defibrillators (Largest Category)

•      Stationary / Fixed-Mount Defibrillators

•      Wearable Defibrillators (Fastest-Growing Category)

 

Analysis by End User

The hospitals & clinics segment held the largest category 35.0% in 2025, encompassing emergency departments, cardiac catheterization labs, intensive care units, operating rooms, and inpatient wards where multiple defibrillator units are stationed for immediate intervention. Hospitals typically maintain a substantial defibrillator installed base across crash carts and dedicated cardiac care equipment, with regulatory accreditation requirements including The Joint Commission standards in the U.S., NHS Quality Standards in the UK, and JCI international accreditation mandating defibrillator availability and regular operational verification.

 

The public access settings segment will grow at the fastest CAGR of approximately 10.0% during the forecast period, driven by expanding government mandates for AED deployment in airports, schools, sports venues, shopping centers, transportation hubs, and corporate buildings globally. Government-funded deployment programs are accelerating segment growth, the UK's GBP 19 million school AED initiative, France's mandatory deployment law, Japan's continued public sector AED expansion, and Australia's Heart of the Nation registry program.

 

End User categories include:

•      Hospitals & Clinics (Largest Category)

•      Pre-hospital Care

•      Public Access Settings (Fastest-Growing Category)

•      Ambulatory Surgical Centers

•      Home Care

•      Others

By Region

External Defibrillator Market Regional Analysis

North America held the largest market share of 44.0% in 2025, underpinned by the world's largest medical device market, the most extensive public access defibrillation infrastructure, and substantial federal and state government investment in cardiac emergency response capability. The United States hosts the largest installed AED base globally, supported by mandates across all 50 states for AED placement in schools, athletic facilities, and public buildings. The Cardiac Arrest Registry to Enhance Survival (CARES) program, supported by CDC funding across over 1,800 EMS agencies, provides comprehensive outcome data driving evidence-based AED deployment. Canada's Public Health Agency has supported nationwide AED registry programs across provinces, while the federal government's healthcare transfers to provinces include cardiac emergency response infrastructure. The region benefits from the highest concentration of certified AED users, robust EMS integration with hospital cardiac care systems, and the most mature public access defibrillation programs globally.

 

Asia-Pacific will grow at the fastest CAGR of approximately 11.0% during the forecast period, propelled by rapidly expanding healthcare infrastructure, government-led emergency cardiac care initiatives, and growing public awareness of sudden cardiac arrest response. Japan operates the highest per-capita AED density globally with approximately 700,000 deployed AEDs supported by Ministry of Health, Labour and Welfare oversight. India's Ayushman Bharat Health Infrastructure Mission with INR 64,180 crore (USD 7.7 billion) outlay supports cardiac emergency capability expansion. South Korea's National Health Insurance Service has expanded AED reimbursement, and the Korean Centers for Disease Control has driven nationwide AED deployment programs. Australia's federal and state government grants exceeding AUD 4 million through Heart of the Nation have registered over 25,000 AEDs. The growing regional medical tourism sector, expanding hospital construction, and rising government emergency preparedness investment are creating substantial premium device demand.

 

Countries and regions include:

North America (Largest Regional Market)

o    U.S. (Larger and Faster-Growing Country Market)

o    Canada

• Europe

o      Germany (Largest Country Market)

o      U.K. (Fastest-Growing Country Market)

o      France

o      Italy

o      Spain

o      Rest of Europe

• Asia Pacific (Fastest-Growing Regional Market)

o      China (Largest Country Market)

o      India (Fastest-Growing Country Market)

o      Japan

o      South Korea

o      Australia

o      Rest of APAC

• Latin America

o     Brazil (Largest Country Market)

o     Mexico (Fastest-Growing Country Market)

o     Rest of LATAM

• Middle East and Africa

o      Saudi Arabia (Largest Country Market)

o      South Africa (Fastest-Growing Country Market)

o      U.A.E.

o      Rest of MEA

Market Share

The global external defibrillator market is moderately consolidated, because a limited number of large multinational medical device companies account for a major share of overall market revenues, particularly in professional and public access automated external defibrillators (AEDs). These established manufacturers have strong global distribution networks, advanced research and development capabilities, extensive regulatory approvals, and well-recognized product portfolios, allowing them to maintain a competitive advantage across hospitals, emergency medical services, and public safety applications. Professional defibrillators used in hospitals and ambulances, along with public access AEDs installed in airports, schools, offices, malls, and stadiums, generate significant revenues that are largely controlled by these leading firms. The market also includes specialized companies that focus on wearable cardioverter defibrillators designed for patients at high risk of sudden cardiac arrest. These niche players contribute to innovation in wearable cardiac monitoring and emergency response technologies, helping diversify the competitive landscape.

 

Key Players Covered

•      Stryker Corporation - Physio-Control (U.S.)

•      Philips Healthcare (Netherlands)

•      ZOLL Medical Corporation - Asahi Kasei (U.S.)

•      Defibtech, LLC (U.S.)

•      Cardiac Science Corporation (U.S.)

•      Nihon Kohden Corporation (Japan)

•      Mindray Medical International Limited (China)

•      Schiller AG (Switzerland)

•      HeartSine Technologies LLC - Stryker (U.S.)

•      Mediana Co., Ltd. (South Korea)

•      CU Medical Systems Inc. (South Korea)

•      BPL Medical Technologies (India)

•      Metrax GmbH - PRIMEDIC (Germany)

•      Bexen Cardio - Osatu S. Coop. (Spain)

•      Progetti Srl (Italy)

 

Market News

•      In December 2025, ZOLL Medical Corporation announced the U.S. launch of the next-generation (fifth FDA-approved) LifeVest wearable cardioverter defibrillator (WCD), incorporating an AI-enhanced algorithm and working seamlessly with the recently launched next-generation LifeVest WCD garment, reinforcing the company's leadership in the wearable cardioverter defibrillator category for at-risk ambulatory cardiac patients.

 

•      In January 2026, Heartstream launched as an independent emergency care company after Emergency Care Holdings (ECH), backed by Bridgefield Capital, acquired the Philips Emergency Care business from Royal Philips, including the HeartStart AED portfolio under a multi-year Philips brand licensing agreement.

 

•      In November 2024, Schiller AG launched the FRED easy G2 defibrillator as part of its 50th anniversary product launches, expanding its emergency care and resuscitation portfolio.

 

•      In December 2025, BPL Medical Technologies launched the Relife 1000 biphasic defibrillator at ISACON 2025 alongside new critical-care devices, expanding its emergency response and cardiac care portfolio.

Frequently Asked Questions